Alignment Healthcare Statistics
Total Valuation
ALHC has a market cap or net worth of $4.47 billion. The enterprise value is $4.12 billion.
Important Dates
The next confirmed earnings date is Thursday, April 30, 2026, after market close.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALHC has 204.30 million shares outstanding. The number of shares has increased by 3.78% in one year.
| Current Share Class | 204.30M |
| Shares Outstanding | 204.30M |
| Shares Change (YoY) | +3.78% |
| Shares Change (QoQ) | -3.81% |
| Owned by Insiders (%) | 4.68% |
| Owned by Institutions (%) | 87.98% |
| Float | 168.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 47.87 |
| PS Ratio | 1.11 |
| Forward PS | 0.83 |
| PB Ratio | 23.86 |
| P/TBV Ratio | 30.59 |
| P/FCF Ratio | 38.57 |
| P/OCF Ratio | 31.19 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 89.34, with an EV/FCF ratio of 36.41.
| EV / Earnings | n/a |
| EV / Sales | 1.04 |
| EV / EBITDA | 89.34 |
| EV / EBIT | 253.28 |
| EV / FCF | 36.41 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.85.
| Current Ratio | 1.71 |
| Quick Ratio | 1.66 |
| Debt / Equity | 1.85 |
| Debt / EBITDA | 6.77 |
| Debt / FCF | 2.93 |
| Interest Coverage | 1.03 |
Financial Efficiency
Return on equity (ROE) is -0.70% and return on invested capital (ROIC) is 2.16%.
| Return on Equity (ROE) | -0.70% |
| Return on Assets (ROA) | 1.10% |
| Return on Invested Capital (ROIC) | 2.16% |
| Return on Capital Employed (ROCE) | 3.20% |
| Weighted Average Cost of Capital (WACC) | 10.36% |
| Revenue Per Employee | $2.14M |
| Profits Per Employee | -$392 |
| Employee Count | 1,849 |
| Asset Turnover | 4.27 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALHC has paid $20,000 in taxes.
| Income Tax | 20,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.89% in the last 52 weeks. The beta is 1.20, so ALHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +24.89% |
| 50-Day Moving Average | 19.36 |
| 200-Day Moving Average | 18.05 |
| Relative Strength Index (RSI) | 63.83 |
| Average Volume (20 Days) | 3,468,209 |
Short Selling Information
The latest short interest is 16.96 million, so 8.30% of the outstanding shares have been sold short.
| Short Interest | 16.96M |
| Short Previous Month | 16.38M |
| Short % of Shares Out | 8.30% |
| Short % of Float | 10.07% |
| Short Ratio (days to cover) | 4.91 |
Income Statement
In the last 12 months, ALHC had revenue of $3.95 billion and -$724,000 in losses. Loss per share was -$0.00.
| Revenue | 3.95B |
| Gross Profit | 488.56M |
| Operating Income | 16.27M |
| Pretax Income | -958,000 |
| Net Income | -724,000 |
| EBITDA | 46.11M |
| EBIT | 16.27M |
| Loss Per Share | -$0.00 |
Full Income StatementBalance Sheet
The company has $604.23 million in cash and $331.60 million in debt, giving a net cash position of $244.22 million or $1.20 per share.
| Cash & Cash Equivalents | 604.23M |
| Total Debt | 331.60M |
| Net Cash | 244.22M |
| Net Cash Per Share | $1.20 |
| Equity (Book Value) | 179.28M |
| Book Value Per Share | 0.88 |
| Working Capital | 394.71M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $139.93 million and capital expenditures -$26.78 million, giving a free cash flow of $113.15 million.
| Operating Cash Flow | 139.93M |
| Capital Expenditures | -26.78M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 113.15M |
| FCF Per Share | $0.55 |
Full Cash Flow StatementMargins
Gross margin is 12.37%, with operating and profit margins of 0.41% and -0.02%.
| Gross Margin | 12.37% |
| Operating Margin | 0.41% |
| Pretax Margin | -0.02% |
| Profit Margin | -0.02% |
| EBITDA Margin | 1.17% |
| EBIT Margin | 0.41% |
| FCF Margin | 2.87% |